Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCN7A (Sodium channel protein type VII alpha subunit) is an atypical voltage-gated sodium channel encoded on chromosome 2 that functions primarily as a sodium leak channel and osmosensor, rather than a conventional depolarization-activated channel. Unlike typical sodium channels that respond to changes in membrane voltage, SCN7A is activated by changes in extracellular sodium concentration and maintains sodium ion homeostasis across various tissues and organs. In glial cells of the central nervous system, it plays a critical role in sensing body-fluid sodium levels and controlling salt intake behavior and voluntary water intake by modulating nearby neurons. The channel also contributes to skin barrier homeostasis by mediating sodium influx into keratinocytes. SCN7A is associated with several disease conditions including cervical cancer, epilepsy, and esophageal squamous cell carcinoma, though the mechanistic relationships remain to be fully elucidated. A significant therapeutic challenge is that human SCN7A has not been functionally validated to the same extent as other sodium channels, and the channel is normally locked in an inactive state in human cells due to membrane lipids blocking the pore, limiting direct pharmacological targeting.
SCN7A functions as a **sodium leak channel** rather than a traditional voltage-gated channel. Unlike conventional voltage-gated sodium channels that respond to membrane depolarization, SCN7A is activated by changes in extracellular sodium concentration. The channel allows sodium to flow through the membrane along its concentration gradient, functioning as an osmosensor to regulate sodium homeostasis. In glial cells of the central nervous system, it senses body-fluid sodium levels and modulates nearby neurons to control salt intake behavior and water intake. The channel is generally insensitive to tetrodotoxin in its native state.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein type VII alpha subunit (SCN7A).